论文部分内容阅读
目的重点探究临床上的抗凝治疗在慢性阻塞性肺疾病实际治疗中的作用及效用。方法将我院2010年3月-2011年2月收治的72例慢性阻塞性肺疾病住院患者分为对照组和观察组各36例,对照组在治疗过程中常规给氧治疗,有效抗生素应用,解痉平喘、止咳祛痰,纠正水电解质失衡、营养支持及激素、呼吸兴奋剂应用,观察组在接受常规治疗的同时使用低分子肝素钙之类的抗凝药物制剂进行辅助治疗。经15d治疗后,观察两组疗效。结果观察组总有效率明显高于对照组,差异具有统计学意义(P<0.05),同时观察组治疗后各项体测指标也要好于对照组。结论临床采用抗凝治疗有助于治疗慢性的阻塞性肺疾病,对提高其临床的治愈率上有积极作用,值得推广。
Objective To explore the role and utility of clinical anticoagulant therapy in the actual treatment of chronic obstructive pulmonary disease. Methods The hospitalized patients with chronic obstructive pulmonary disease in our hospital from March 2010 to February 2011 were divided into control group and observation group, with 36 cases in each group. The control group received conventional oxygen therapy, effective antibiotics, Antispasmodic and antiasthmatic, relieving cough and expectoration, correcting water and electrolyte imbalance, nutrition support and hormone and respiratory stimulant. The observation group received adjuvant therapy with anticoagulant drugs such as low molecular weight heparin while receiving routine treatment. After 15d treatment, the two groups were observed. Results The total effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05), while the observation group after treatment the physical measurement indicators are better than the control group. Conclusion The clinical use of anticoagulant therapy in the treatment of chronic obstructive pulmonary disease has a positive effect on improving the clinical cure rate and is worth promoting.